Analysis | Metabolite Name | Measured Value | Units | genotype | Xoo infection |
---|---|---|---|---|---|
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 88 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 94 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 101 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 103 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 105 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 109 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 121 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 125 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 125 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 128 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 129 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 134 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 138 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 139 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 140 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 142 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 143 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 145 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 145 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 148 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 162 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 165 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 167 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 181 | Peak height | Taipei 309 | mock |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 181 | Peak height | Taipei 309 | no treatment |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 181 | Peak height | Taipei 309 | Pxo99 |
GCMS positive ion mode | pyrazine 2,5-dihydroxy NIST | 192 | Peak height | Taipei 309 | Pxo99 |